Cargando…

Future possibilities in the prevention of breast cancer: Role of genetic variation in breast cancer prevention

Risk factors for breast cancer are related to endogenous hormonesand reproductive events. As such, traditional cancer prevention strategies arenot easily applicable. Tamoxifen and other selective estrogen receptormodulators (SERMs) offer a new preventive strategy for some high-risk women,but have no...

Descripción completa

Detalles Bibliográficos
Autores principales: Feigelson, Heather Spencer, Henderson, Brian E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138788/
https://www.ncbi.nlm.nih.gov/pubmed/11250721
http://dx.doi.org/10.1186/bcr69
_version_ 1782120493107642368
author Feigelson, Heather Spencer
Henderson, Brian E
author_facet Feigelson, Heather Spencer
Henderson, Brian E
author_sort Feigelson, Heather Spencer
collection PubMed
description Risk factors for breast cancer are related to endogenous hormonesand reproductive events. As such, traditional cancer prevention strategies arenot easily applicable. Tamoxifen and other selective estrogen receptormodulators (SERMs) offer a new preventive strategy for some high-risk women,but have not yet been shown to be efficacious for all women. New tools toidentify high-risk women are needed. One such tool is the development of amultigenic model of breast cancer susceptibility that can be used to screenwomen in order to identify those who carry a combination of alleles that putsthem at significantly increased risk.
format Text
id pubmed-138788
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1387882003-02-27 Future possibilities in the prevention of breast cancer: Role of genetic variation in breast cancer prevention Feigelson, Heather Spencer Henderson, Brian E Breast Cancer Res Review Risk factors for breast cancer are related to endogenous hormonesand reproductive events. As such, traditional cancer prevention strategies arenot easily applicable. Tamoxifen and other selective estrogen receptormodulators (SERMs) offer a new preventive strategy for some high-risk women,but have not yet been shown to be efficacious for all women. New tools toidentify high-risk women are needed. One such tool is the development of amultigenic model of breast cancer susceptibility that can be used to screenwomen in order to identify those who carry a combination of alleles that putsthem at significantly increased risk. BioMed Central 2000 2000-05-24 /pmc/articles/PMC138788/ /pubmed/11250721 http://dx.doi.org/10.1186/bcr69 Text en Copyright © 2000 Current Science Ltd
spellingShingle Review
Feigelson, Heather Spencer
Henderson, Brian E
Future possibilities in the prevention of breast cancer: Role of genetic variation in breast cancer prevention
title Future possibilities in the prevention of breast cancer: Role of genetic variation in breast cancer prevention
title_full Future possibilities in the prevention of breast cancer: Role of genetic variation in breast cancer prevention
title_fullStr Future possibilities in the prevention of breast cancer: Role of genetic variation in breast cancer prevention
title_full_unstemmed Future possibilities in the prevention of breast cancer: Role of genetic variation in breast cancer prevention
title_short Future possibilities in the prevention of breast cancer: Role of genetic variation in breast cancer prevention
title_sort future possibilities in the prevention of breast cancer: role of genetic variation in breast cancer prevention
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138788/
https://www.ncbi.nlm.nih.gov/pubmed/11250721
http://dx.doi.org/10.1186/bcr69
work_keys_str_mv AT feigelsonheatherspencer futurepossibilitiesinthepreventionofbreastcancerroleofgeneticvariationinbreastcancerprevention
AT hendersonbriane futurepossibilitiesinthepreventionofbreastcancerroleofgeneticvariationinbreastcancerprevention